Robotic Radiotherapy Market Report 2026

Robotic Radiotherapy Market Overview

• Robotic Radiotherapy market size has reached to $1.17 billion in 2025 • Expected to grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Advancing Precision In Minimally Invasive Treatments • Market Trend: Advancements in Robotic Precision and AI-Powered Cancer Treatment Technologies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Robotic Radiotherapy Market?

Robotic radiotherapy is an advanced cancer treatment method that combines robotic technology with precision radiation delivery to target tumors with sub-millimeter accuracy. It uses real-time imaging and motion tracking to adapt to tumor movement, such as that caused by breathing, ensuring minimal damage to surrounding healthy tissues. This approach allows for non-invasive, highly personalized treatments, improving patient outcomes and reducing side effects. The main products in the robotic radiotherapy market are radiotherapy systems, software, and 3D cameras (surface guided). Radiotherapy systems refer to advanced medical devices and technologies used in the treatment of cancer and other medical conditions through the application of radiation. The various technologies include linear accelerators, conventional linear accelerators, magnetic resonance imaging (MRI) - linear accelerators, stereotactic radiation therapy systems, cyberknife, gamma knife, particle therapy, and proton beam therapy, and several applications including prostate cancer, breast cancer, lung cancer, head and neck cancer, and colorectal cancer. The different end users encompass hospitals and independent radiotherapy centers.

What Is The Robotic Radiotherapy Market Growth Forecast?

The robotic radiotherapy market size is expected to see rapid growth in the next few years. It will grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growing adoption of personalized oncology treatments, rising investments in robotic cancer care infrastructure, increasing demand for motion-adaptive radiotherapy, expansion of proton and particle therapy centers, technological advancements in AI-driven treatment planning. Major trends in the forecast period include increasing adoption of real-time tumor motion tracking, rising use of image-guided robotic radiation systems, growing demand for personalized radiotherapy planning, expansion of non-invasive cancer treatment protocols, enhanced focus on sub-millimeter radiation accuracy.

Global Robotic Radiotherapy Market Segmentation

1) By Product: Radiotherapy Systems, Softwares, 3D Cameras (Surface Guided) 2) By Technology: Linear Accelerators, Conventional Linear Accelerators, Magnetic Resonance Imaging (MRI) - Linear Accelerators, Stereotactic Radiation Therapy Systems, Cyberknife, Gamma Knife, Particle Therapy, Proton Beam Therapy 3) By Application: Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer 4) By End User: Hospitals, Independent Radiotherapy Centers Subsegments: 1) By Radiotherapy Systems: Robotic Linear Accelerators, Proton Therapy Systems, Stereotactic Radiosurgery Systems, Image-Guided Radiotherapy (IGRT) Systems, Intensity-Modulated Radiotherapy (IMRT) Systems 2) By Softwares: Treatment Planning Software, Radiation Therapy Management Software, Robotic Radiotherapy Control Software, Integration Software For Robotic Systems 3) By 3D Cameras (Surface Guided): 3D Optical Surface Imaging Systems, 3D Camera Systems For Patient Positioning, 3D Motion Tracking Cameras For Radiotherapy, Real-Time 3D Surface Imaging For Tumor Localization

What Is The Driver Of The Robotic Radiotherapy Market?

The rise in demand for minimally invasive procedures is expected to propel the growth of the robotic radiotherapy market going forward. Minimally invasive procedures are driven by advancements in medical technology, growing patient preference for reduced recovery times and complications, and increasing adoption by healthcare providers for their cost-effectiveness and improved clinical outcomes. Robotic radiotherapy enhances the precision and effectiveness of minimally invasive procedures by delivering highly targeted radiation doses to tumors while minimizing damage to surrounding healthy tissues, thereby reducing complications, improving recovery times, and aligning with the growing demand for advanced, patient-centric treatment options. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based specialty organization, a 7 percent growth in minimally invasive procedures in 2023 surpassed surgical procedures by 2 percent, with neuromodulator injections and hyaluronic acid fillers each exceeding 9 million and 5 million treatments, respectively. Thus, the rise in demand for minimally invasive procedures is driving the growth of the robotic radiotherapy industry.

Key Players In The Global Robotic Radiotherapy Market

Major companies operating in the robotic radiotherapy market are Siemens Healthineers AG, GE Healthcare Technologies Inc, Varian Medical Systems, Elekta AB, Accuray Incorporated, Brainlab AG, Mevion Medical Systems Inc, ViewRay Technologies Inc, RaySearch Laboratories AB, VisionRT Ltd, MIM Software Inc, CIVCO Radiotherapy, ProNova Solutions, IBA Group, Xcision Medical Systems LLC, C RAD AB, RefleXion Medical Inc, Zap Surgical Systems Inc, Hitachi High Tech Corporation, Toshiba Medical Systems Corporation, Philips Radiation Oncology Systems, Shinva Medical Instrument Co Ltd, Neusoft Medical Systems Co Ltd, United Imaging Healthcare Radiotherapy

Global Robotic Radiotherapy Market Trends and Insights

Major companies operating in robotic radiotherapy market are focusing on developing innovative products with advanced technologies, such as artificial intelligence (AI) precision to perform tasks with exceptional accuracy, consistency, and minimal error. Robotic precision enhances accuracy, reduces human error, improves consistency, minimizes tissue damage, and accelerates recovery using sensors, actuators, and algorithms. For instance, in January 2024, Tampa General Hospital, a US-based cancer institute, launched CyberKnife S7, an AI-powered radiosurgery tool. This technology marks a significant progression in the field of cancer care, offering a non-invasive and precise treatment option for patients with a variety of conditions, including both benign and malignant tumors, as well as neurological disorders. The CyberKnife S7 enables targeted radiation delivery, minimizing damage to surrounding healthy tissues, and providing a less invasive alternative to traditional surgical methods.

What Are Latest Mergers And Acquisitions In The Robotic Radiotherapy Market?

In April 2024, GE HealthCare, a US-based provider of medical imaging systems, diagnostic technologies, and digital healthcare solutions, acquired MIM Software for an undisclosed amount. With this acquisition, GE HealthCare aims to strengthen its precision care strategy by integrating advanced AI-driven imaging analytics and radiation oncology workflow solutions to enhance clinical efficiency and treatment personalization. MIM Software is a US-based provider of artificial intelligence-enabled software for radiation oncology, molecular radiotherapy, diagnostic imaging, and urology, serving hospitals, imaging centers, and research institutions worldwide.

Regional Outlook

North America was the largest region in the robotic radiotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Robotic Radiotherapy Market?

The robotic radiotherapy market consists of revenues earned by entities by providing services such as treatment planning services, imaging and diagnostics, robotic system operation, and maintenance. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic radiotherapy market also includes sales of linear accelerators, radiotherapy accessories, immobilization devices, shielding equipment, and fiducial markers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Robotic Radiotherapy Market Report 2026?

The robotic radiotherapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the robotic radiotherapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.